APTIVUS

Drug Boehringer Ingelheim Pharmaceuticals, Inc.
Total Payments
$83,521
Transactions
27
Doctors
10
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $37.02 2 2
2019 $39,616 11 4
2018 $43,868 14 7

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $83,480 24 100.0%
Food and Beverage $40.89 3 0.0%

Top Doctors Receiving Payments for APTIVUS

Doctor Specialty Location Total Records
, MD Urology Dallas, TX $21,624 7
, M.D Specialist Aventura, FL $19,900 7
, MD Urology New York, NY $15,322 6
, MD Urology New York, NY $9,452 1
, M.D Family Medicine Brooklyn, NY $6,302 1
, M.D Family Medicine Providence, RI $6,302 1
, MD Urology Miami, FL $4,578 1
, D.O Family Medicine Bensalem, PA $18.51 1
, D.O Emergency Medicine Bensalem, PA $18.51 1
, MD Internal Medicine Bronx, NY $3.87 1

About APTIVUS

APTIVUS is a drug associated with $83,521 in payments to 10 healthcare providers, recorded across 27 transactions in the CMS Open Payments database. The primary manufacturer is Boehringer Ingelheim Pharmaceuticals, Inc..

Payment data is available from 2018 to 2020. In 2020, $37.02 was paid across 2 transactions to 2 doctors.

The most common payment nature for APTIVUS is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($83,480, 100.0% of total).